Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
- PMID: 35719954
- PMCID: PMC9202593
- DOI: 10.3389/fonc.2022.896927
Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
Abstract
Triple-negative breast cancer (TNBC) is the subtype with the worst prognosis of breast cancer. Ferroptosis, a novel iron-dependent programmed cell death, has an increasingly important role in tumorigenesis and development. However, there is still a lack of research on the relationship between ferroptosis-related genes and the prognosis of TNBC. In this study, we obtained the gene expression profile of TNBC patients and matched clinical data from The Cancer Genome Atlas (TCGA) database. Univariate Cox analysis was used to screen out ferroptosis-related genes associated with TNBC prognosis. Then, the least absolute shrinkage and selection operator (LASSO) regression analysis was employed to establish a prognostic prediction model. A 15-ferroptosis-related gene prognostic prediction model was developed, which classified patients into low-risk (LR) or high-risk (HR) groups. Kaplan-Meier analysis results showed that the prognosis of the LR group was better. The receiver operating characteristic (ROC) curve also confirmed the satisfactory predictive ability of this model. Evaluation of the immune microenvironment of TNBC patients in the HR and LR group suggested these 15 ferroptosis-related genes might affect the prognosis of TNBC by regulating the tumor microenvironment. Our prognostic model can provide a theoretical basis for accurate prognosis prediction of TNBC in clinical practice.
Keywords: ferroptosis; mRNA signature; prognostic model; triple-negative breast cancer (TNBC); tumor microenvironment.
Copyright © 2022 Wu, Pan, Lu, Wu, Xie, Tang and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Construction of a novel five programmed cell death-related gene signature as a promising prognostic model for triple negative breast cancer.PeerJ. 2025 Apr 28;13:e19359. doi: 10.7717/peerj.19359. eCollection 2025. PeerJ. 2025. PMID: 40313394 Free PMC article.
-
An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.BMC Cancer. 2022 Jun 7;22(1):619. doi: 10.1186/s12885-022-09679-x. BMC Cancer. 2022. PMID: 35668369 Free PMC article.
-
Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.J Cell Mol Med. 2021 Dec;25(23):10950-10960. doi: 10.1111/jcmm.17013. Epub 2021 Nov 5. J Cell Mol Med. 2021. PMID: 34741393 Free PMC article.
-
Ferroptosis: the emerging player in remodeling triple-negative breast cancer.Front Immunol. 2023 Oct 20;14:1284057. doi: 10.3389/fimmu.2023.1284057. eCollection 2023. Front Immunol. 2023. PMID: 37928550 Free PMC article. Review.
-
Iron-Dependent Cell Death: Exploring Ferroptosis as a Unique Target in Triple-Negative Breast Cancer Management.Cancer Manag Res. 2025 Mar 19;17:625-637. doi: 10.2147/CMAR.S503932. eCollection 2025. Cancer Manag Res. 2025. PMID: 40124838 Free PMC article. Review.
Cited by
-
Identification of Molecular Subtypes and Prognostic Features for Triple-Negative Breast Cancer Based on Golgi Apparatus-Related Gene Signature.Oncol Res. 2025 Jul 18;33(8):2013-2035. doi: 10.32604/or.2025.061757. eCollection 2025. Oncol Res. 2025. PMID: 40746884 Free PMC article.
-
Identification and validation of mRNA profiles linked to ATP- induced cell death represent a novel prognostic model for breast cancer.Front Immunol. 2024 Nov 1;15:1483498. doi: 10.3389/fimmu.2024.1483498. eCollection 2024. Front Immunol. 2024. PMID: 39555060 Free PMC article.
-
Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.Sci Rep. 2023 Dec 8;13(1):21916. doi: 10.1038/s41598-023-49136-8. Sci Rep. 2023. PMID: 38081931 Free PMC article.
-
Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer.Oncol Lett. 2023 Dec 5;27(2):43. doi: 10.3892/ol.2023.14176. eCollection 2024 Feb. Oncol Lett. 2023. PMID: 38106522 Free PMC article.
-
SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.Front Immunol. 2024 Apr 19;15:1369892. doi: 10.3389/fimmu.2024.1369892. eCollection 2024. Front Immunol. 2024. PMID: 38707897 Free PMC article.
References
-
- Garrido-Castro AC, Lin NU, Polyak K. Insights Into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov (2019) 9(2):176–98. doi: 10.1158/2159-8290.CD-18-1177 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources